Platelet-Rich Plasma vs Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint

NCT01920373 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was cancelled.

Conditions

Degenerative Joint Disease

Interventions

DRUG: Group A (corticosteroid injection group)
BIOLOGICAL: Group B (platelet rich plasma injection group)

Sponsor

Kaiser Permanente